P

Protagonist Therapeutics
D

PTGX

122.760
USD
0.54
(0.44%)
مغلق
حجم التداول
34,110
الربح لكل سهم
5
العائد الربحي
-
P/E
-68
حجم السوق
7,894,864,149
أصول ذات صلة المقالات
المزيد

العنوان: Protagonist Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.